Novozymes CSO buys stock for more than EUR 110,000
![Photo: Novozymes/PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12505280.ece/ALTERNATES/schema-16_9/doc7cvacgdrsu1o5x9mmec.jpg)
Claus Crone Fuglsang, chief science officer and senior vice president of research and development at Novozymes, bought 2,110 shares in the Danish enzyme group on Thursday at an average share price of DKK 387.93.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novozymes reorganizes to strengthen customer focus
For subscribers
Novozymes maintains investment plans despite pandemic
For subscribers